References
- Alarcon GS, Kremer JM, Macaluso M, Weinblatt ME, Cannon GW, Palmer WR, Risk factors for methotrexate-induced lung injury in patients with rheumatoid arthritis. A multicenter, case-control study. Methotrexate-Lung Study Group. Ann Intern Med 1997; 127:356–64.
- Imokawa S, Colby TV, Leslie KO, Helmers RA. Methotrexate pneumonitis: review of the literature and histopathological findings in nine patients. Eur Respir J 2000;15:373–81.
- Sawada T, Inokuma S, Sato T, Otsuka T, Saeki Y, Takeuchi T, Leflunomide-induced interstitial lung disease: prevalence and risk factors in Japanese patients with rheumatoid arthritis. Rheumatology (Oxford) 2009;48:1069–72.
- Ju JH, Kim SI, Lee JH, Lee SI, Yoo WH, Choe JY, Risk of interstitial lung disease associated with leflunomide treatment in Korean patients with rheumatoid arthritis. Arthritis Rheum 2007;56:2094–6.
- Savage RL, Highton J, Boyd IW, Chapman P. Pneumonitis associated with leflunomide: a profile of New Zealand and Australian reports. Intern Med J 2006;36:162–9.
- Namba T, Tanaka KI, Ito Y, Hoshino T, Matoyama M, Yamakawa N, Induction of EMT-like phenotypes by an active metabolite of leflunomide and its contribution to pulmonary fibrosis. Cell Death Differ 2010;17:1882–95.
- Sato T, Inokuma S, Sagawa A, Matsuda T, Takemura T, Otsuka T, Factors associated with fatal outcome of leflunomide-induced lung injury in Japanese patients with rheumatoid arthritis. Rheumatology (Oxford) 2009;48:1265–8.
- Bartram SA. Experience with methotrexate-associated pneumonitis in northeastern England: comment on the article by Kremer et al. Arthritis Rheum 1998;41:1327–8.
- Carroll GJ, Thomas R, Phatouros CC, Atchison MH, Leslie AL, Cook NJ, Incidence, prevalence and possible risk factors for pneumonitis in patients with rheumatoid arthritis receiving methotrexate. J Rheumatol 1994;21:51–4.
- Kremer JM, Genovese MC, Cannon GW, Caldwell JR, Cush JJ, Furst DE, Concomitant leflunomide therapy in patients with active rheumatoid arthritis despite stable doses of methotrexate. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 2002;137:726–33.